We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| SGS SA (PK) | USOTC:SGSOY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.07 | -0.79% | 8.84 | 8.67 | 9.01 | 8.8605 | 8.84 | 8.8605 | 107,817 | 21:04:15 |
From Jun 2019 to Jun 2024
SGS (SGSN.VX) said Friday it acquired Belgium's Exprimo NV for an undisclosed sum, to expand its services and technologies in life sciences.
MAIN FACTS:
-Exprimo is a European life science consultancy company with strong focus in the application of quantitative, model-based simulations during all stages of pharmaceutical development.
-Founded in 2002 and privately owned, Exprimo employs 16 experts in Belgium, United Kingdom, Sweden, The Netherlands, France and Switzerland. In 2011, they generated revenues in excess of EUR3 million.
-"SGS continues to expand its breadth of services and technologies in our Life Science Services. With this new expertise, we will enhance our service offerings towards existing and potential clients and leverage our network," said Chris Kirk, CEO of SGS.
-Zurich Bureau, Dow Jones Newswires, +41 43 443 80 47; zurichdjnews@dowjones.com
1 Year SGS (PK) Chart |
1 Month SGS (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
